South Korea Introduced First 8-Inch SiC Plant in Busan, Annual Output Projected at 30K Wafers

Sep 18, 2025- by CMI| Category : Advanced Materials1 min read
South Korea Introduced First 8-Inch SiC Plant in Busan, Annual Output Projected at 30K Wafers

South Korea has taken a major step forward in its semiconductor ambitions with the completion of its first 8‑inch silicon carbide (SiC) power semiconductor plant in Busan. On September 17, 2025, the Busan Metropolitan Government and IQ Lab Co. Ltd. held a ceremony to officially inaugurate the IQ Lab headquarters and production facility in Jangan‑eup, Gijang‑gun.

This facility is the nation’s first full‑process production factory for 8‑inch SiC power semiconductors, capable of both in‑house manufacturing and foundry services. After test operations slated for the remainder of 2025, full‑scale production is scheduled to begin in 2026. Annual production capacity is expected to reach 30,000 wafers.

Construction began in June 2024, following an investment agreement (MOU) signed in October 2023 between IQ Lab and Busan authorities. Busan supported the project by providing about 5 billion won in investment incentives, moving approvals faster, and aiding licensing processes. The total project cost is around 100 billion won, with the facility covering roughly 8,750 square meters of land and 7,322 square meters of building space.

Beyond manufacturing, the plant aims to bolster local talent: over 200 jobs will be created, and one floor of the office building will host a field campus (RISE) dedicated to power semiconductors, helping Busan and the surrounding Gyeongnam region strengthen its industry‑academia linkages.

Government officials emphasized that this development lays a foundation for localizing advanced SiC semiconductor processes, reducing dependency on imports, and positioning Busan as a future hub for power semiconductor innovation.

Share this story

About the author

Ravina Pandya

is a seasoned content writer with over 3.5 years of hands-on experience across various writing formats, including news articles, blog posts, press releases, and informational content. Her expertise lies in producing high-quality, informative content tailored to meet the specific needs of diverse industries, such as Biotechnology, Clinical Diagnostic, Healthcare IT, advanced material, and Medical Devices. She has a deep understanding of how to craft engaging narratives that align with industry trends, helping businesses enhance their online presence and communicate effectively with their audiences.

What sets Ravina apart is her keen eye for detail and her passion for storytelling. She approaches every piece of content with the intent to make it not just informative but also impactful, ensuring that it resonates with the audience on a deeper level. With a reputation for producing timely and relevant articles, she has made significant contributions to the field by helping companies effectively communicate their brand message through engaging, clear, and creative writing. As an advocate for clarity in communication, she continues to explore new ways of refining her craft while remaining at the forefront of content trends.